Commercial vaccines provide limited protection to NADC30-like PRRSV infection.
暂无分享,去创建一个
Yingying Li | Xiangdong Li | K. Tian | X. Bai | Yuzhou Wang | Zhe Sun | G. Ji | Yan Xiao | F. Tan | Xin Xu
暂无分享,去创建一个
Yingying Li | Xiangdong Li | K. Tian | X. Bai | Yuzhou Wang | Zhe Sun | G. Ji | Yan Xiao | F. Tan | Xin Xu